A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma
Reardon, David A., Desjardins, Annick, Rixe, Olivier, Cloughesy, Timothy, Alekar, Shilpa, Williams, Jason H., Li, Ray, Taylor, Carrie Turich, Lassman, Andrew B.Journal:
Investigational New Drugs
DOI:
10.1007/s10637-020-00950-1
Date:
May, 2020
File:
PDF, 501 KB
2020
File converter
More search results
More benefits 
